Thymosin Alpha-1 10 mg β Immune System Peptide for Advanced Research | Peptide Hubs
Thymosin Alpha-1 (TΞ±1) is a synthetic 28-amino acid peptide fragment derived from prothymosin alpha, designed to support immune regulation, enhance host defense mechanisms, and balance T-cell activity. Supplied in a 10 mg (2 mL) vial by Peptide Hubs, this higher-dosed research format enables extended protocols or high-demand studies, particularly in cancer immunology, viral defense, and anti-aging models.
What Is Thymosin Alpha-1?
Thymosin Alpha-1 is a naturally occurring thymic peptide known for modulating both innate and adaptive immunity. It activates T lymphocytes and natural killer cells while helping regulate inflammatory cytokines. Research has explored its potential in combating viral infections, supporting vaccine efficacy, and enhancing immune function during aging or chronic illness. According to data published on PubMed, TΞ±1 can influence toll-like receptors and dendritic cell activity, making it a compelling candidate for modern immunotherapy research.
Lab Test Result

Research Applications
- Immune system modulation and rebalancing
- Viral immunity models (HBV, HCV, HIV, COVID-19)
- Oncology studies involving immune checkpoint regulation
- Longevity and immunosenescence research
- Autoimmune modulation and chronic inflammation protocols
Recommended Dosage Protocol
In laboratory studies, Thymosin Alpha-1 is typically used at 2β6 mg per week, administered subcutaneously in divided doses (e.g., 1β2 mg every 2β3 days). Research cycles vary from 2 to 6 weeks depending on the study focus. This 10 mg vial is well-suited for prolonged research timelines or multiple subject groups.
Suggested Peptide Combinations
Thymosin Alpha-1 is often combined with other immune or regenerative peptides to maximize multi-pathway modulation:
- Thymalin β supports thymic rejuvenation and immune maturation
- Selank β studied for its neuroimmune balance and anxiolytic effects
- BPC-157 β assists in inflammation modulation and tissue repair
- GHK-Cu β promotes skin healing, DNA repair, and antioxidant defense
- AOD 9604 β researched in fat metabolism and immune-linked metabolic regulation
Safety Profile
Thymosin Alpha-1 is non-hormonal and has demonstrated a strong safety profile in animal and early human trials. It is not associated with liver or kidney toxicity, and it does not influence testosterone, estrogen, or growth hormone pathways. It is important to note that this peptide is for research use only and is not approved by the FDA for human consumption.
USA Domestic Shipping & Research Compliance
Peptide Hubs offers fast and secure USA domestic shipping on Thymosin Alpha-1 10 mg and all peptides in our catalog. All batches are manufactured in GMP-compliant labs and subject to strict quality controls. For extended immune support research, consider combining with SS-31 to explore mitochondrial and immunological synergy.
Frequently Asked Questions
What is Thymosin Alpha-1 used for in research?
Thymosin Alpha-1 is studied for its immunomodulatory effects, especially in viral defense, cancer immunity, and anti-aging applications.
How is Thymosin Alpha-1 typically administered in studies?
It is commonly administered subcutaneously at doses of 1β2 mg multiple times per week, depending on the protocol.
Can Thymosin Alpha-1 be combined with other peptides?
Yes, it is frequently stacked with peptides like Thymalin, Selank, or GHK-Cu for comprehensive immune and regenerative support.
Is Thymosin Alpha-1 approved for human use?
No, Thymosin Alpha-1 is not FDA-approved and is intended strictly for research purposes only.
No reviews found
Please log in to write Thymosin Alpha-1 10 mg review.